ARTICLE | Company News
Eyetech Pharmaceuticals, Iomed deal
October 30, 2000 8:00 AM UTC
The companies will test EyeTech's EYE001 anti-angiogenic agent delivered by IOX's non-invasive OcuPhor transscleral drug delivery system to prevent age-related macular degeneration. EYE001 is in Phas...